BPA, anavorx distribution LLC, anascorp injections, phoenix area wide
Ended Awarded
- Contract number
- 75H71224A00013
- Awardee
-
Rare Disease Therapeutics, Inc. UEI M7B1ABSZJKX8
- Awarding agency
-
Indian Health Service
Department of Health and Human Services
- Task orders
- 3 $27,645 obligated
Award facts
- Opportunity
-
- Intent to Sole Source Award, Anavorx Distribution LLC, IHS, Phoenix Area, Anascorp Scorpion Antivenom Special Notice · IHS1489441PAO · Posted Jun 24, 2024
- Combined order value
- $27,645 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 11% used
- $248,000.00
- Maximum order
- $248,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded Rare Disease Therapeutics, Inc. a $250,000 Blanket Purchase Agreement (BPA) to provide the VA with access to the company's catalog of specialty pharmaceutical products, particularly orphan drugs for rare diseases. This single-award IDV leverages Rare Disease Therapeutics' GSA Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), allowing efficient procurement of these specialized medications.
The Indian Health Service (IHS) also awarded Rare Disease Therapeutics a $393,849 BPA to deliver pharmaceutical injections, specifically the scorpion antivenom ANASCORP, to IHS clinics through May 2024. This IDV, also based on the company's GSA Schedule contract, supports IHS facilities primarily in Arizona that serve tribal nations. In addition, Rare Disease Therapeutics has provided ANASCORP and other antivenin supplies to the Smithsonian Institution's National Zoo under previous federal contract awards.
Task orders
Quick answers
Who was awarded contract 75H71224A00013?
75H71224A00013 was awarded to Rare Disease Therapeutics, Inc. by Indian Health Service (Department of Health and Human Services) on July 19, 2024.
How much is contract 75H71224A00013 worth?
Orders under 75H71224A00013 have obligated $27,645. 75H71224A00013's own ceiling is $248,000. A single order can be worth up to $248,000.
How many orders have been placed under contract 75H71224A00013?
3 orders have been placed under 75H71224A00013, the latest on March 24, 2025.
Who can order from contract 75H71224A00013?
75H71224A00013 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 75H71224A00013 under another contract?
Yes. 75H71224A00013 is a blanket purchase agreement under 36F79718D0404, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 75H71224A00013 competed?
The extent of competition for 75H71224A00013 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV